Diagnostic Testing of STDs Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


The global diagnostic testing of STDs market is estimated to be valued at US$ 10.4 Bn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. 

Market Overview:

Diagnostic testing of STDs involves evaluating samples from infected individuals for the presence of viruses, bacteria, or parasites that cause sexually transmitted diseases. This allows for early detection and timely treatment, reducing the risk of complications.

Market key trends: 

One of the major trends in the diagnostic testing of STDs market is increasing adoption of telehealth services. STDs often cause stigma and embarrassment, deterring people from getting tested. Telehealth allows anonymous screening from the comfort of one's home. Users can order self-collection testing kits online, get tested without face-to-face interaction with a healthcare professional, and receive results and treatment recommendations digitally. This addresses privacy concerns and barriers to testing, supporting early detection efforts. The COVID-19 pandemic accelerated digitalization of healthcare including telehealth, further propelling this trend.

Read More Insights @ https://www.coherentmarketinsights.com/market-insight/diagnostic-testing-of-stds-market-3917

Segment Analysis

The diagnostic testing of STDs market is segmented into laboratory testing and point of care testing. The laboratory testing segment dominates the market and accounted for around 70% share in 2023. The laboratory testing segment involves examination of samples such as blood, urine, and tissues collected from patients in laboratories with high-end equipment. It offers accurate diagnosis through DNA amplification and culture-based tests. The accuracy and reliability of diagnostic results have made laboratory testing the most preferred method for STD diagnosis.

Key Takeaways

The global diagnostic testing of STDs market is expected to witness high growth, exhibiting CAGR of 9.6% over the forecast period, due to increasing prevalence of STDs worldwide.

Regional analysis

North America dominated the global market and accounted for over 35% share in 2023 owing to rising awareness about STD diagnosis and availability of advanced diagnostic infrastructure in the region. Asia Pacific is expected to exhibit fastest growth over the forecast period supported by increasing healthcare spending and expanding patient pool in emerging economies like China and India.

Key players

Key players operating in the diagnostic testing of STDs market are Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories. Roche Holdings AG holds leading market share owing to its robust product portfolio and global distribution network.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

The Where and the How: Unraveling Biology's Spatial Enigma with Omics

-
Image
In the fast-evolving landscape of biomedical research, a revolutionary technique has emerged that promises to unlock new dimensions of understanding within cellular landscapes – Spatial Omics. This cutting-edge approach combines the power of genomics, transcriptomics, proteomics, and more, with spatial information, creating a holistic view of biological systems. At its core, Spatial Omics involves mapping the molecular composition of tissues with spatial context. Traditional omics techniques provide valuable insights into the molecules present in a sample, but they lack the crucial information about where these molecules are located within the tissue. Spatial Omics bridges this gap by preserving the spatial architecture, offering unprecedented insights into cellular interactions, organization, and function. Read More @   https://www.digitaljournal.com/pr/news/coherent-market-insights/spatial-omics-market-revenue-growth-rate-customer-needs-trend-manufacturers-and-forecast-to-2030-10...
Read more

Fertility And Pregnancy Rapid Test Kits Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-
Image
The global Fertility And Pregnancy Rapid Test Kits Market is estimated to be valued at US$ 1,451.9 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.  Market Overview:  Pregnancy Rapid Test kits help in early detection of pregnancy in women. They are easy-to-usekits providing quick results within 5-10 minutes without laboratory or medical assistance.  Market key trends:  One of the key trends driving growth in the fertility and pregnancy rapid test kits market is increasing demand for home use pregnancy and ovulation prediction test kits. Manufacturers are focusing on making test kits more affordable and convenient for home use without medical supervision. Portable personal fertility monitors that track various fertility signs like cervical mucus, basal body temperature, etc on a mobile app are gaining popularity. The increasing use of digital technology in ...
Read more